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Abstract.  Osteogenetic protein-1  (OP-1), a member of 
the TGF-B superfamily, induces endochondral bone 
formation at subcutaneous sites in vivo and stimulates 
osteoblastic phenotypic expression in vitro. Pri- 
mary cultures of newborn rat calvarial cells contain a 
spectrum of osteogenic phenotypes ranging from un- 
differentiated mesenchymal osteoprogenitor cells to 
parathyroid hormone (PTH)-responsive osteoblasts. 
We examined whether treatment of this cell population 
with recombinant human osteogenic protein-1  could 
induce chondrogenesis in vitro. Markers of chondro- 
blastic versus osteoblastic differentiation included al- 
cian blue staining  at pH  1, alkaline phosphatase-specific 
activity, osteocalcin radioimmunoassay, and expression 
of collagen mRNAs. 6 d of treatment (culture days 
1-7) with 4-100 ng OP-1/ml caused dose-dependent in- 
creases in alcian blue staining intensity and alkaline 
phosphatase activity (4.7- and 3.4-fold, respectively, at 
40 ng/ml), while osteocalcin production decreased 
twofold. Clusters of round, refractile, alcian 
blue-stained cells appeared by day 3, increased in 
number until day 7, and then became hypertrophic and 
gradually became less distinct.  Histochemically, the 
day 7 clusters were associated with high alkaline phos- 
phatase activity and became mineralized, mRNA tran- 
scripts for collagen types II and IX were increased by 
OP-1, peaking at day 4,  while type X collagen mRNA 
was detectable only on day 7 in OP-l-treated cultures. 
Delay of OP-1 exposure until confluence (day 7) am- 
plifies expression of the normal osteoblastic phenotype 
and accelerates its developmental maturation. In con- 
trast, early OP-1 treatment commencing on day 1 
strongly amplifies chondroblastic differentiation. In the 
same protocol, TGF-BI alone at 0.01-40  ng/ml fails to 
induce any hypertrophic chondrocytes, and in combi- 
nation with OP-1, TGF-B1 blocks OP-l-dependent 
chondroinduction. OP-1 is believed to act on a sub- 
population of primitive osteoprogenitor cells to induce 
endochondral ossification, but does not appear to 
reverse committed osteoblasts to the chondrocyte 
phenotype. 
B 
ONE  matrix contains various  growth factors  which 
control bone formation and resorption, and these fac- 
tors clearly play important roles in the development 
and growth of cartilage  and bone (Hauschka  et al.,  1986; 
Centrella et al., 1987; Hauschka,  1990). Implantation of de- 
mineralized bone matrix at intramuscular or subcutaneous 
sites induces cartilage and bone formation (Reddi and Hug- 
gins, 1972; Urist, 1965). Recently, several proteins involved 
in ectopic bone formation have been purified  from bovine 
demineralized bone matrix, allowing  the cloning  of their 
full-length  cDNAs and discovery of related cDNAs:  bone 
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morphogenetic proteins (BMPs) ~ (BMP-1 through BMP-7) 
(Wong et al.,  1988; Wozney et al.,  1988; Celeste et al., 
1990); osteogenin (BMP-3) (Lug.ten  et al., 1989); and osteo- 
genic protein-1 (OP-1/BMP-7)..(Ozkaynak  et al., 1990; Sam- 
path et al., 1990) and OP-2 (Ozkaynak et al., 1992). cDNA 
sequencing has revealed that these proteins are members of 
the superfamily of  TGF-/5-related proteins which share a dis- 
tinctive pattern of seven cysteine residues in their COOH- 
terminal domains (Celeste  et al.,  1990; Ozkaynak et al., 
1990; Wozney et al.,  1988). 
The members of the TGF-/~ superfamily play diverse and 
significant roles in growth and differentiation. For example, 
Drosophila decapentaplegic  complex (dpp)  is  involved in 
embryonic  dorsal/ventral  polarity  (Segal  and  Gelbart, 
1. Abbreviations  used in this paper: BME bone morphogenetic protein; OP, 
osteogenic protein; TFA, trifluoracetic acid. 
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mesoderm induction in Xenopus (Rebagliati et al.,  1985). 
Vgr-1 (BMP-6)  and BMP-2 (BMP-2a)  expression has been 
analyzed in  various tissues during mouse embryogenesis 
(Lyons et al., 1989).  BMPs and OP-1 are thought to be in- 
volved in cartilage and bone development. 
Formation of new bone is induced when OP-1 and other 
BMPs are implanted with carriers in nonbony sites in rats. 
This induction always involves  the cascade of de novo en- 
dochondral bone formation: cartilage is  induced and be- 
comes calcified before being replaced by mineralized bone 
(Reddi, 1981; Sampath et al., 1992). Several in vitro studies 
have addressed the mechanism of action of bone-inducing 
proteins. These studies have shown that BMPs and OP-1 have 
two osteogenic effects. First, they enhance the osteoblastic 
characteristics of osteoblast-like cells, including MC3T3-E1 
mouse  calvaria-derived  osteoblasts  (BMP-2  and  BMP-3) 
(Hiraki et al.,  1991; Takuwa et al.,  1991; Vukicevic  et al., 
1990), and rat calvaria-derived primary osteoblast-like cells 
(BMP-3  [Vukicevic et al.,  1989]; BMP-4 [Chen, T., et al., 
1991]; OP-1 [Sampath et al., 1992]).  Second, these factors 
induce osteoblast phenotypic expression by osteoprogenitor 
cells such as rat calvaria-derived cells (BMP-2;  Yamaguchi 
et al.,  1991), bone marrow stromal cells (BMP-2;  Thies et 
al.,  1991), and C3HlffI'I/2 mouse embryo-derived mesen- 
chymal cells (BMP-2;  Katagiri et al., 1990).  Other studies 
focussing on cartilage showed that native preparations of 
BMP-2/BMP-3  (Hiraki et al.,  1991), BMP-3 alone (Vuki- 
cevic et al., 1989),  and BMP-4 (Luyten et al.,  1992) could 
enhance cartilage characteristics of cultured articular chon- 
drocytes. Osteogenin (BMP-3)  and BMP-4 have also been 
noted  to  induce  the  cartilage  phenotype  in  chondrocyte 
precursor chick limb bud cells (Carrington et al.,  1991; 
Chen, P., et al., 1991), and to promote reexpression of carti- 
lage phenotype by dedifferentiated articular chondrocytes 
(Harrison et al., 1991). However, there has been no evidence 
until our study that OP-1 or other BMPs could induce chon- 
drogenesis in noncartilage cells in vitro. 
In  contrast  to  the  endochondral  development  of long 
bones, membranous fiat bones of  the skull (e.g., calvaria) de- 
velop  by  intramembranous  ossification,  bypassing  the 
calcified cartilage stage characteristic of the endochondral 
process. In postfetal life, however, when injury or insult oc- 
curs, skull bones repair through a cellular process which in- 
cludes both intramembranous and endochondral ossification 
(Marden et al., 1993). Might OP-1 and other BMPs play an 
intrinsic role in osseous healing? It is possible that chondro- 
cytes and osteoblasts are developed by differentiating from 
the same common lineage of uncommitted mesenchymal os- 
teoprogenitor cells, although the identity of the OP-1 target 
cell and the precise lineage leading to chondrocyte and os- 
teoblast phenotypes is not clearly established. 
While exploring the temporal dependence of OP-1 regula- 
tion of primary rat osteoblasts in vitro, we observed strong 
chondroinduction  resulting  from  early  OP-1 treatment, 
whereas if left untreated, these cultures would have naturally 
progressed to mature, mineralizing osteoblasts without evi- 
dence of cartilage.  We hypothesized that OP-1 has chon- 
droinductive effects on a  subset of uncommitted osteopro- 
genitor cells derived from neonatal rat calvaria, and that the 
combined OP-1 effects of chondroinduction (this study) and 
the known osteogenic stimulation of committed osteoblasts 
(Sampath et al.,  1992) could account for the in vivo obser- 
vations that OP-1 induces the cascade of endochondral ossi- 
fication. 
Materials and Methods 
Preparation of  Recombinant Human OP-I 
Recombinant human OP-1  (OP-1) was prepared as described previously 
(Sampath et al., 1992). Briefly, the full-length OP-1 eDNA was inserted into 
a  mammalian expression vector and transfected into dhfr(-) CHO cells 
which were subjected to methotrexate-mediated gene amplification. The 
resulting selected cell line was cultured in roller bottles, and the conditioned 
media was collected. OP-1 was purified from conditioned media using three 
chromatography steps: S-Sepharose, phenyl-Sepharose, and reverse phase 
HPLC  (Sampath  et  al.,  1992).  Mature  OP-1  is  a  glycosylated 36-kD 
homodimer of 139-amino acid residue chains. Stock solutions of  OP-I were 
prepared in 50% ethanol, 0.1% trifluoroacetic acid (TFA) and standardized 
for protein concentration by amino acid analysis. 
Cell Culture 
Calvaria from 1-d-old Spragae-Dawley rats (Charles River Laboratories, 
Wilmington, MA) were dissected, and five sequential 20-rain digests (I-V) 
were performed on suture-free calvarial fragments at 37°C in Hefley's buffer 
(Hefley  et  al.,  1981) containing  2  mg/ml  collagenase  B  (Boehringer- 
Mannheim Corp.,  Indianapolis,  IN)  and 0.25%  trypsin (GIBCO  BRL, 
Gaithersburg, MD). Single cell suspensions obtained from digests III to V 
were pooled. In some experiments, calvaria were separated into four ana- 
tomical regions (frontal bone, parietal bone, occipital bone, and sutures) 
and digested separately as described above. Cells were plated on day 0 in 
MEM (Sigma Chemical Co., St. Louis, MO) supplemented with 10% FBS 
(Bioproducts for Science Inc., Indianapolis, IN) and antibiotics (100 U/ml 
penicillin G and 10O #g/mi streptomycin; GIBCO BRL) in 12-multiwell 
plates (Elkay,  Shrewsbury, MA) at a density of 1.2  ×  105 cells per 1-ml 
well. Treatment with OP-1 and 50 #g/mi L-ascorbic acid (Sigma Chemical 
Co.) was started 1 d after plating, and medium was replaced completely ev- 
ery 3 d beginning on day 1. To examine the effect of OP-1 on mineralization, 
10  ram  ~-glycerophosphate (Sigma  Chemical  Co.)  was  added  to  the 
medium from day  1. 
All OP-1 additions to cultured cells involved rapid dispersal of <10  -3 
vol of OP-1 stock solution (in 50%  ethanol, 0.1%  TFA) into the culture 
medium  immediately before rereading  cells;  solvent vehicle alone  was 
added to control medium. 
Human, recombinant TGF-~I (R & D Systems, Minneapolis, MN) was 
prepared at 20 #g/ml in 4 mM HC1 containing 1 mg/ml  BSA. TGF-~I or 
control vehicle was added to medium before refeeding. 
For experiments examining the effect of OP-I on chondrogenesis versus 
osteogenesis, primary cultures were compared with subcultivated cell col- 
tures. Subcultivation was performed by trypsin digestion of day 7 confluent 
primary cultures grown in the absence of OP-1 and ascorbic acid.  The 
washed cell suspension was diluted to 1.2  x  105 cells/ml and replated un- 
der the same conditions as the primary culture. 
Cell  Growth 
Effects of OP-1 on cell growth were examined by determining the rate of 
[3H]thymidine  incorporation into total acid-insoluble DNA and by mea- 
surement of total DNA in cell layers. 
DNA synthesis rates were determined after every 3 d of treatment with 
OP-1 by adding  [3H-methyl]thymidine (50  Ci/mmol;  Amersham Corp., 
Arlington Heights, IL). Cells were labeled with 2 #Ci/ml of [3H]thymidine 
for 4 h before termination of  the culture. The 5 % TCA-precipitated radioac- 
tive DNA in the cell layer was solubilized with 0.5 N NaOH and qnantitated 
by liquid scintillation counting. 
DNA content was determined by fluorometric assay (Vytasek,  1982). 
Cells were precipitated with 5 % TCA, dissolved in 1 N NaOH, hydrolyzed 
in 1 N perehloric acid at 70°C for 20 min, and incubated with diaminoben- 
zoic acid dihydrochloride at 37°C for 1 h. DNA concentration was deter- 
mined against a calf thymus DNA standard (Sigma Chemical Co.) by mea- 
suring the fluorescence emission at 500 rim during excitation at 408 nm 
using a Perkin Elmer LS-5 fluorescence spectrophotometer (Perkin-Elmer 
Corp., Norwalk, CT). 
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The degree of chondrogenesis was evaluated by staining with alcian blue. 
Cultures were washed with PBS, fixed 10 rain with 4% paraformaldehyde, 
stained with 0.5% alcian blue (Fluka, Ronkonkoma, NY) in 0.1 N HCI, pH 
1.0, overnight, and rinsed with distilled water.  The quantity of sulfated 
glycosaminoglycan representative of cartilage  matrix  was  estimated by 
measuring the amount of extractable dye (San Antonio and Tuan,  1985). 
Alcian blue-stained cultures were extracted with 6 M guanidine-HC1 for 
2 h at room temperature. Optical density of the extracted dye was measured 
at 650 nm in a 96-well plate reader (Molecular Devices, Menlo Park, CA). 
Alkaline Phosphatase Activity 
Cell layers were extracted with 20 mM TBS, pH 7.4, containing 1% Triton 
X-100 and stored at  -20°C until the assay.  Enzyme activity was assayed 
with 10 mM (final) p-nitrophenyl phosphate as a substrate in 50 mM sodium 
carbonate buffer, pH 10, containing 5 mM MgC12. After 10 min of incuba- 
tion at 37°C, the reaction was stopped with 0.5 N NaOH and absorbance 
was measured at 405 nm. Protein in each sample was determined with the 
BCA protein assay kit (Pierce, Rockford, IL). Alkaline phosphatase specific 
activity is presented as ttmol p-nitrophenol produced/min/ttg protein. 
Osteocalcin Radioimmunoassay 
Rat osteocalcin levels in the media were measured by radioimmunoassay 
as described previously (Gundberg et al., 1984). Conditioned medium sam- 
pies were collected and  stored at  -20°C.  Radioimmunoassay was per- 
formed using goat anti-rat osteocalcin serum as first antibody and donkey 
anti-goat IgG as second antibody. The intraassay and interassay variance 
was +  5% and +  8%, respectively. Data are expressed as total ng rat os- 
teocalcin in the 3-d-conditioned medium per #g cell layer DNA. 
Histochemical Analysis 
Cell layers were rinsed with PBS or 0.9% NaC1, and fixed with 4% parafor- 
maldehyde. Fixed cell layers were stained with 0.5% alcian blue or 0.1% 
toluidine blue to examine chondrogenesis. For alkaline phosphatase, fixed 
cells were incubated with 0.125%  fl-naphthyl phosphate and 0.5%  fast 
blue RR salt in  100  mM Tris buffer, pH 8.8, containing 5  mM MgC12. 
Mineral deposition was assessed by a modified yon Kossa staining tech- 
nique. After 30 rain of incubation with 3 % AgNO3 in the dark, cell layers 
were exposed for 30 s to 254-nm ultraviolet light on a viewing box to rapidly 
develop the black silver phosphate nodules. To visualize cells undergoing 
DNA  replication (S-phase),  [3H]thymidine-treated cultures were coated 
with Kodak NTB2  emulsion for autoradiography (Eastman Kodak Co., 
Rochester, NY) and counterstained with Giemsa after development. 
Northern Analysis 
For Northern analysis, cells were plated in 6-multiwell plates at a density 
of 3.6  ×  105 cells per 2-ml/well and cultured for 4, 7, and 10 d in media 
containing 0, 4, and 40 ng OP-1/rnl. Total  RNA was extracted by the acid 
guanidine thiocyanate-phenol-chloroform method (Chomczynski and Sac- 
chi,  1987).  Briefly,  after washing with cold PBS, the cells were homoge- 
nized in Solution D, which contained 4 M guanidine thiocyanate, 25 mM 
sodium citrate, 0.5 % N-lauroyl-sarcosine, 10 mM tmns-l,2-diaminocyclo- 
hexane-N,N,N',N'-tetraacetic  acid  (CDTA),  and  100  mM  /~-mercap- 
toethanol, pH 7.15. One volume of water-saturated phenol, 0.2 volume of 
chloroform-isoamyl alcohol (49:1),  and 0.1 volume of 2 M sodium acetate, 
pH 4.0,  were added to the homogenate, and total RNA was extracted into 
the aqueous phase after centrifugation. Isopropanol-precipitated RNA was 
again solubilized in Solution D and reextracted by the same procedure to 
increase purity. 
5-,~g samples of total  RNA  were electrophoretically resolved in  1% 
formaldehyde agarose  gels  and  transferred  to  nylon  membrane  filters 
(Nytran;  Schleicher &  Schuell, Keene, NH) by capillary blotting. Filter 
blots were prehybridized 4 h at 45°C with buffer containing 50%  forma- 
mide, 5x SSPE, 5x Denhardt's solution, 1% SDS and 25/~g/ml of salmon 
sperm DNA. Hybridizations were carried out for 16 h at 45°C with buffer 
containing 50%  formamide, 5x  SSPE, 1% SDS,  10% dextran sulfate, 25 
~g/ml of salmon sperm DNA, and the desired eDNA probe labeled with 
[tx32P]-dCTP  by  random  priming  (Kit;  Boehringer  Mannheim  Corp.). 
Probes included the cDNA for rat t~l(I) collagen (Genovese et al.,  1984), 
rat pro-ul(II) collagen (Kohno et al.,  1984),  rat ~l(IX) collagen and rat 
a)(X)  collagen  (Nishimura,  I.,  unpublished  observation),  and  mouse 
glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH)  (Sabath  et  al., 
1990).  After washing the filters, autoradiograms were made at  -80°C by 
exposure to Kodak XAR-5 film (Eastman Kodak Co.). 
Results 
Cell Growth 
Effects of OP-1 on cell proliferation were evaluated in two 
ways:  [3H]thymidine  incorporation  into  acid-insoluble 
DNA, and total DNA content of cell layers. OP-1 stimulates 
DNA synthesis in the early stages of culture where cells are 
sparse and generally proliferating. A  120 % stimulatory ef- 
fect of OP-1 is significant at day 4, but there are no apparent 
differences in  pH]thymidine incorporation between OP-1- 
treated cultures and control cultures after confluence (day 
10-13)  (Fig. 1 B). At day 7, [3H]thymidine incorporation is 
increased 55 and 50% by 20 and 40 ng/ml of OP-1, respec- 
tively. OP-1 at 100 ng/ml does not significantly elevate label- 
ing, in part because cultures with this high dose have reached 
confluence by this 7-d assay point (Fig. 1 A). These results 
on cell proliferation are confirmed by measurements of DNA 
content. Although OP-1 increases DNA content by 30-60 % 
in a dose-dependent manner at day 7 (Fig. 1, Cand D), sig- 
nificant differences in DNA content are not observed after 
day 10 (Fig.  1 D). 
Chondrogenic Differentiation 
Alcian blue staining of sulfated glycosaminoglycan  was used 
to evaluate chondrogenesis, since the production of this extra- 
cellular matrix component is a hallmark of chondrogenesis 
(Hunter and Caplan, 1983). The intensity of  alcian blue stain- 
ing shows dose-dependent increase caused by OP-1 (Fig. 2 
A). Induction of alcian blue-stained colonies in OP-l-tw, ated 
cultures peaks at day 7, and the intensity of the staining de- 
creases gradually at later times (Fig. 2 B). Clusters of round, 
refractile, alcian blue-stained cells appear within two days 
after treatment with OP-1 (day 3), and increase in both size 
and number until day 7.  These cells then become enlarged 
and hypertrophic, and gradually disappear. Although the in- 
tensity of alcian blue staining in control cultures increases 
gradually by day 13 (Fig. 2 B), this is caused by diffuse bind- 
ing of dye to the entire cell layer; histological examination 
shows total absence of alcian blue-stained colonies, in con- 
trast to their abundance in OP-l-treated cultures. 
Analysis of the dose dependence of the OP-1 induction of 
chondrocytic cell clusters was carded out by plating cells on 
day 0 in the presence of  different concentrations of  OP-1 (Fig. 
2  C).  On day 5,  wells were scored for total numbers of 
"clonal" clusters containing three or more cells.  Fig.  2  C 
shows that concentrations of 10 ng/ml OP-1 or greater induce 
a highly significant increase in the number of these clusters, 
with a fourfold increase over background at I0 rig/m1 and a 
50-fold increase at 320 ng/ml. 
Northern analysis of mRNA levels was performed with 
collagen type I, II, IX, and X cDNAs to evaluate the chon- 
drocytic properties of OP-l-induced ceUs. Type II collagen 
mRNA is increased by OP-1 treatment in a dose-dependent 
manner, while type I  collagen message decreases slightly 
(Fig. 3, I and II). Interestingly, short form type IX collagen 
message is expressed even in control cultures, while long 
form type IX collagen message is expressed only in OP-1 
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Figure 1. OP-1 effects on cell proliferation, showing the dose dependence (A) and time course (B) of [3H]thymidine incorporation into 
acid-insoluble DNA, and the dose dependence (C) and time course (D) of changes in DNA content of cell layers. Cell layers were pulse 
labeled with [3H]thymidine  (2 #Ci/ml, 4 h) before harvest (A and B). DNA was quantitated in cell layers (C and D) by the fluorometric 
diarninobenzoic acid method. For dose dependence, cells were cultured with graded concentrations of  OP-1 for 6 d from day 1 and harvested 
at day 7. For kinetics, cells were cultured without OP-1 (e) or with 40 ng/ml OP-1 (o) from days 1-13, and harvested every 3 d beginning 
on day 1. Data represent the mean + SD of  three cultures for each treatment and are representative of  three separate experiments. Asterisk, 
significant difference from control; P <  0.05. 
treated cultures (Fig. 3,/X). Type II and IX collagen mes- 
sages peak at day 4 and then gradually decrease. OP-1 in- 
duced the expression of type X collagen message only at day 
7 in the culture treated with 40 ng/ml of OP-1 (Fig. 3, X). 
Alkaline Phosphatase Activity 
Alkaline  phosphatase-specific  activity  is  significantly  in- 
creased by OP-1 in a dose-dependent manner; 3.4- and 4.5- 
fold at 40 and 100 ng/ml OP-1, respectively (Fig. 4 A). Activ- 
ity in  the  OP-1 treated cultures peaks at day 7  and then 
decreases slightly (Fig. 4 B). In contrast, alkaline phospha- 
tase in control cultures increases gradually throughout the 
culture period (Fig. 4 B). 
Osteocalcin Production 
Although  the  amount  of osteocalcin production  in  early 
primary cultures (1-2 ng//zg DNA) is far less than in mature 
cultures, OP-1 decreases osteocalcin production in a dose- 
dependent manner at day 7 (Fig. 5 A). However, once the cul- 
tures have become confluent (days 10 and 13), the osteocal- 
cin production becomes 10- to 20-fold greater than on day 
7,  and OP-1 significantly increases osteocalcin production 
(Fig. 5 B). 
OP-1 Responsiveness of  Different Calvarial 
Cell Populations 
The histology of the developing rat calvaria features plates 
of membranous bone separated by fibrous sutures.  At the 
outer limbs of the lambdoidal suture are remnants of the 
chondrocranium, from which Rifas et al.  (1982) were able 
to derive chondrocytes by selective culture conditions. We 
examined  the  OP-1 response  of cells  from  anatomically 
different regions of calvaria (frontal, parietal, and occipital 
bones, and sutures) (Table I). Cells from all regions showed 
OP-l-dependent increases of 1.5-3-fold in alcian blue stain- 
ing, and 2.1-6-fold increases in alkaline phosphatase specific 
activity.  It is  noteworthy that untreated cultures  from all 
regions have low alcian blue staining  (Table I), indicating 
that few, if any,  differentiated chondrocytes exist in any of 
these anatomical regions prior to culture in the presence of 
OP-1. However, the occipital and parietal populations appear 
to have a greater number of cells with OP-l-dependent chon- 
drogenic potential. 
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Figure 2. OP-1 effects on chondrogenesis, showing the dose depen- 
dence (A) and time course (B) of the intensity of alcian blue staining 
(A~o m). The protocol for cell culture is described in Fig.  1; for 
B, cells were cultured without OP-I (e) or with 40 ng/ml OP-I (o). 
After fixation,  cell layers were stained with 0.5%  alcian blue in 
0.1 N HCI and rinsed; the extracted dye was quantitated by A650n~ 
in 96-well plates (see Materials and Methods).  Data represent the 
mean -t- SD of three cultures for each treatment and are representa- 
tive of three separate experiments. Effect of OP-1 on induction of 
chondrocyte colonies (C). Calvarial cells were plated at 1.1  ×  105 
cells/cm  2 in 96-well plates in the presence of increasing concentra- 
tions of OP-1. 5 d later, plates were fixed in 4 % paraformaldehyde, 
stained  with toluidine  blue,  and  scored for the total number of 
chondrocytic  clusters  of three  or more ceils per well.  Asterisk, 
significantly different from minus OP-1 control; P  <  0.05. 
Sequential enzymatic digestion of calvarial bone segments 
in  the  standard  protocol  (frontal  +  parietal  +  occipital, 
trimmed free of sutures) releases cells with increased osteo- 
blastic properties in later digests  (Wong and Cohn,  1975). 
Similarly, we found that the chondrogenic potential increases 
significantly in later digests.  OP-1 treatment (40 ng/ml, 6 d) 
causes increases in alcian blue staining of 1.66-fold in digest 
I  cells,  2.54-fold in digest II, and  3.04-fold in pooled cells 
from digests III-V. The alkaline phosphatase in all three cell 
populations  was elevated 5-6-fold by OP-1. 
Effect of OP-1 on Osteoblastic  Cell Populations of 
Different Age 
Chondrogenic  differentiation  in  this  model  system  is  ob- 
served  only  when  primary  cultures  are  treated  early  with 
OP-1 from day 0  (Fig. 2  C) or day 1 (Fig. 2, A and B; Table 
II).  Quantitatively,  alcian blue staining  of the day  1-7 cul- 
tures increases 3.9-fold in response to OP-1, while the same 
duration of OP-1 treatment of confluent day 7-13 or subculti- 
vated cultures causes little chondroinduction  (Table I.I). Al- 
though  the  intensity  of alcian  blue  dye  uptake  (A6~m)  by 
day 7-13 and subcultivated cultures with or without OP-1 ex- 
hibits a  relatively high background,  no alcian blue-stained 
cartilage-like clusters are observed histologically.  Alkaline 
phosphatase specific activity, a marker for chondrocytes and 
osteoblasts, is also enhanced to a greater magnitude by OP-1 
in primary cultures treated with OP-1 from day 1 (3.21-fold) 
than in more mature day 7-13 cultures or subcultivated cul- 
tures (Table 11). However, the mature osteoblast marker os- 
Figure 3. Northern analysis of gene expression, showing the effects 
of OP-1 on mRNA synthesis of collagen type I (I), type 11 (H), type 
IX (/X), and type X (X). Cells were cultured for 3 d  (lanes 1, 2, 
and 3), 6 d (lanes 4, 5, and 6), and 9 d (lanes 7, 8, and 9), with 
OP-1 treatment at 0 ng/ml (lanes 1, 4, and 7), 4 ng/ml (lanes 2, 5, 
and 8), and 40 ng/ml (lanes 3, 6, and 9) beginning on day 1. Total 
RNA was extracted from each culture and Northern analysis was 
performed  as  described.  Equivalent  loading  of  total  RNA  (5 
#g/lane) was verified by UV absorbance, ethidium bromide stain- 
ing, and hybridization with a mouse GAPDH eDNA probe (bottom 
panels). For the analysis of types I and lI collagen, and types IX and 
X collagen, the same filters wdre used. Arrows mark the collagen 
gene  transcript  size(s)  for  each  collagen  type  detected  by  the 
specific eDNA probe. The positions of 28 S and  18 S ribosomal 
RNA are also indicated. 
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Figure 5. OP-1 effects on osteocalcin production, showing dose dependence (A) and time course (B) of osteocalcin levels in 3-d conditioned 
medium. The experimental protocol  is described in Fig.  1; for B, cells were cultured without OP-I (e) or with 40 ng/ml OP-1 (o). Os- 
teocalcin was measured by specific radioimmunoassay. Data are expressed as total ng rat osteocalcin/#g  cell layer DNA. Data represent 
the mean +SD of three cultures for each treatment and are representative of three separate experiments. Asterisk, significant difference 
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Table L  OP-I Effects on Different  Calvarial 
Cell Populations 
Calvarial 
region  OP-1  Alcian blue staining  Alkaline phosphatase 
A(650) nm)  T/C  #mol/min/#g  protein  T/C 
Frontal  -  0.117  +  .010  0.279  +  .048 
+  0.186  5-  .007  1.59  0.709  5-  .048  2.54 
Parietal  -  0.190  5-  .002  0.437  5-  .025 
+  0.503  5-  .046  2.65  1.299  5-  .168  2.97 
Occipital  -  0.177  +  .018  0.121  5-  .014 
+  0.525  5-  .033  2.97  0.731  5-  .127  6.04 
Suture  -  0.181  5-  .006  0.579  5-  .048 
+  0.265  5-  .014  1.46  1.216  5-  .021  2.10 
Calvarial  regions  were  microdissected into  pools containing  anatomically 
defined regions (frontal bone, parietal bone, etc.). Cells from each region were 
enzymatically dissociated and plated at equal density on day 0 (see Materials 
and Methods);  OP-I treatment (40 ng/ml) was from days 1-7. Data represent 
mean  +SD  from  three  replicate  wells  and  are  representative  of several 
independent experiments.  All ratios of OP-I treated to control (T/C) showed 
significant OP-1 effects (P <  0.05). 
teocalcin is decreased by OP-1  in primary cultures treated 
from day 1, but increased in subcultivated cell cultures (Ta- 
ble II). Thus, early treatment (days 1-7) with OP-1 elicits the 
greatest chondrogenic response (alcian blue, alkaline phos- 
phatase)  and a  diminished  osteogenic response  (osteocal- 
cin);  late OP-1  treatment elicits minimal chondrogenic re- 
sponse and an enhanced osteoblastic response. 
Effect of  Ascorbic Acid and fl-Glycerophosphate 
OP-t treatment  in the  absence of ascorbic acid  increases 
chondrogenesis  and alkaline phosphatase activity slightly, 
but these phenotypic properties are greatly increased when 
OP-1  is used in the presence of ascorbic acid (Table m). 
~Glycerophosphate has no significant effect on the induction 
of chondrogenesis and alkaline phosphatase activity by OP-1 
(Table HI).  Osteocalcin  production  is decreased by early 
OP-1  treatment (Table l/I;  also Fig.  5  and Table IV).  Al- 
though this OP-l-dependent decrease still occurs in the pres- 
ence  of ascorbate  +  B-glycerophosphate,  the  addition  of 
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Cell 
population  OP-1  Alcian blue staining  Alkaline phosphatase activity  Osteocalcin 
A (650 nm)  T/C  lunol/min/l~g protein  T/C  ng/#g DNA  T/C 
Days  1-7  -  0.087  +  .005  0.490  +  .033  1.77  +  0.07 
+  0.339  5:.014  3.90*  1.573  5:.101  3.21"  0.68  ±  0.10  0.38* 
Days  7-13  -  0.245  +  .015  0.637  5:.028  4.35  5:0.34 
+  0.289  5:.005  1.18"  0.785  +  .067  1.23"  4.97  +  0.80  1.14 
Subcult.  -  0.202  5:.009  0.560  +  .056  4.14  5:0.26 
+  0.212  5:.020  1.05  1.186  5:.031  2.12"  7.70  5:1.54  1.86" 
Cell cultures were established (see Materials and Methods) and treated with or without 40 ng/ml OP-1 for 6 d before analysis. Days 1-7 indicates early treatment 
of subconfluent cells initiated on day  1 (cells were plated on day 0).  Days 7-13 indicates late treatment after cells have reached confluence. Subcult. indicates 
treatment of subcultivated ceils which was initiated the day after trypsinization and replating of a day 7 culture.  Data represent means 5: SD from three replicate 
wells and are representative  of several independent experiments. 
* Ratios of OP-1 treated to control (T/C) which showed significant OP-1 effects (P <  0.05). 
Table IlL Dependence of OP-1 Effects on Ascorbate and F3-Glycerophosphate (~GP) 
Treatment 
group  OP-I  Alcian blue staining  Alkaline phosphatase activity  Osteocalcin 
A(650 nm)  T/C  #mol/min/l~g  protein  T/C  ng/ml  T/C 
Control  -  0.038 +  .003  0.011  +  .002  0.032 +  .043 
+  0.048 _+ .002  1.26  0.022 +  .003  2.00  0.007 +  .011  0.22 
+Ascorbate  -  0,086 +  .002  0.053 +  .005  9.48 +  .25 
+  0,276 +  .021  3.21"  0,204 +  .036  3.85*  6.57 +  .41  0.69* 
+Asc  +/3GP  -  0.087 +  .002  0.053 +  .011  13.34 +  .65 
+  0.316 +  ,013  3.63*  0.201  +  .031  3.79*  9.66 +  1.75  0.72* 
Cell cultures were established on day 0 and treated from days 1-7 with ascorbate alone (50 #g/ml), or with ascorbate  +  ~-glycerophosphate (10 mM), or without 
these additives (Control). These three groups were also treated with 40 ng/ml OP-1 (+) or vehicle (-) from days  1-7 before analysis.  Data represent means + 
SD from three  replicate wells and are representative  of several independent experiments. 
* Ratios of OP-1 treated to control (T/C) which showed significant OP-I effects (P <  0.05). 
/~-glycerophosphate elevates  basal  osteocalcin production 
compared to ascorbate alone (Table HI). 
Morphological and Histochemical Changes Induced 
by oP-1 
The biochemical evidence for OP-l-dependent chondroin- 
duction is consistent with histological evaluations. Cultures 
treated  with  OP-1 have  abundant  clusters  of round  cells 
which are stained with alcian blue intensively (Fig. 6 B). In 
contrast, there are no alcian blue-stained colonies in control 
cultures, while small colonies of  tightly compacted, flattened 
cells are observed (Fig. 6 A). Staining of OP-1 treated cul- 
tures with toluidine blue shows red/purple metachromasia of 
these colonies (Fig. 6 H). Histochemically, strong alkaline 
phosphatase staining is observed for both the large, round 
chondrocyte-like cells  and  the  small,  compact  cells  sur- 
rounding these chondrocytes in OP-l-treated cultures (Fig. 
6 D). In control cultures, the chondrocytic colonies are ab- 
sent and alkaline phosphatase is restricted to tightly com- 
pacted cell colonies (Fig. 6 C).  Mineralization of primary 
cultures occurs in the day 7-13 period only if 10 mM/3-glyc- 
erophosphate is added to the medium,  yon Kossa staining 
shows strong mineralization in OP-l-treated cultures. Exten- 
sive mineralization occurs on the periphery of each large 
round  cell  in  the  chondrocyte-like  cell  clusters  in  OP- 
1-treated cultures (Fig. 6 F), while only a small amount of 
mineralization is observed in control cultures at day 7 (Fig. 
6 E). Autoradiograms of [3H]thymidine-labeled cultures at 
day 4 show that small cells surrounding the clusters of large 
round chondrocytic cells  incorporate [3H]thymidine pros- 
perously, while the large cells within the colonies do not 
(Fig. 6  G). 
TGF-~I Antagonism of OP-1 Effects 
Because OP-1 is  a  member of the  TGF-/3  superfamily of 
growth and differentiation factors, comparative studies of 
OP-1 and TGF-~I  were initiated in this chondroinduction 
model system. These two factors share 34 % identity in their 
7-cysteine domain  (Ozkaynak et  al.,  1990).  Histological 
(Fig. 7) and biochemical (Table IV) changes associated with 
OP-l-dependent chondrogenesis are not seen with TGF-/~I 
over a dose range of 0.01-40 ng/ml. Furthermore, the chon- 
drogenesis induced by 40 ng/mi of OP-1  alone (4.84-fold 
increase in alcian blue,  1.47-fold increase in alkaline phos- 
phatase; Table IV) is strongly antagonized by TGF-/31 con- 
centrations of 1 and 10 ng/ml (Fig. 7; Table IV). TGF-~I also 
diminishes osteoblastic parameters osteocalcin and alkaline 
phosphatase (Table IV). Histologically, TGF-fll changed the 
normal polygonal cell shape to a fibroblastic spindle shape 
(Fig. 7). 
Discussion 
Evidence That OP-1 Induces Chondrogenesis In Vitro 
We present evidence that OP-1 induces chondrogenesis in a 
primary culture model system initiated from newborn rat 
calvaria.  Morphologically,  chondrocytic colonies  appear 
within two days after treatment with OP-1, and these distinc- 
Asahina et al.  Chondrocyte Induction by Osteogenic Protein-1  927 Figure 6. Histological  changes induced by OP-1. Phase contrast micrographs of alcian blue staining (A and B), alkaline phosphatase staining 
(C and D), and von Kossa staining (E and F); autoradiogram of [3H]thymidine  incorporation into DNA (G); light micrograph of tolu- 
idine blue staining (H). Cells were cultured without OP-1 (A, C, and E) or with 40 ng/ml of OP-1 (B, D, F, and H) for 6 d  from day 
1, and the effects of OP-1 on chondrogenesis (A, B, and H) alkaline phosphatase activity (C and D) and mineralization (E and F) were 
examined at day 7. For autoradiography (G), cells were cultured with 40 ng/ml of OP-1 for 3 d from day 1, pulsed with [3H]thymidine 
for 4  h, and autoradiographed. 
The Journal of Cell Biology,  Volume 123, 1993  928 Figure 7. TGF-B1 antagonism of OP-1 chondroinduction. Phase-contrast micrographs are shown for the control culture (A), and cultures 
treated with either 1 ng/ml TGF-/51 (B), 40 ng/ml OP-1 (C),  or 1 ng/ml TGF-B1 and 40 ng/ml OP-1 (D) for 6 d from day 1. 
tive cell clusters increase in both number and size before be- 
coming  hypertrophied.  Chondrocytic  cell  clusters  stain 
heavily with alcian blue, stain metachromatically with tolu- 
idine blue, express high alkaline phosphatase activity, and 
act as loci for the initiation of mineralization which first oc- 
curs  in  and  around  the  hypertrophic  chondrocytic cells. 
These sequential changes have strong parallels to the process 
of endochondral bone formation in vivo, as discussed below. 
Table IV.  TGF-B1 Antagonism  of OP-1 Induced 
Phenotypic  Changes 
Treatment 
Ratio of treated/control 
Alcian blue  Alkaline phosphatase 
TGF-B1  OP-I  staining  activity  Osteocalcin 
ng/ml 
-  --  1.00  1.000  1.000 
0.1  -  0.98  0.367*  0.094* 
1  --  0.99  0.083*  0.056* 
1  40  1.41"  0.250*  0.055* 
10  -  1.09  0.058"  0.062* 
10  40  1.43"  0.215"  0.059* 
-  40  4.84*  1.465*  0.242* 
Cell cultures were established (see Materials and Methods) and treated with or 
without various doses of TGF-/~I and/or OP-1 for 6 d (culture day 1-7) before 
analysis.  Data were calculated from means of three  replicate wells;  standard 
deviations  are  +5%  for aleian blue  staining,  and  + 12%  for alkaline phos- 
phatase activity and osteoealcin. 
* Ratios of treated to control values which showed significant differences from 
the untreated control  (P ~  0.05), 
Expression of cartilage-associated type II and IX collagen 
genes is enhanced in the early stages after exposure to OP-1, 
and then gradually decreases. It is noteworthy that long-form 
type IX collagen is expressed only in cultures treated with 
OP-1, while type II and short-form type IX collagens are ex- 
pressed even in control cultures. Although the association of 
type II and IX collagens with chondrogenesis is well estab- 
lished  (vonder  Mark,  1980;  Heinegard  and  Paulsson, 
1987), type II collagen is also expressed in a variety of other 
tissues  during  embryogenesis,  thus  it  is  not  a  definitive 
marker for the chondrocyte phenotype (Chah et al.,  1991; 
Kosher and Solursh, 1989). Type IX collagen can be synthe- 
sized in two distinct forms due to differential mRNA tran- 
scription  of  the  od(IX)  gene,  using  alternative  promo- 
tor/transcriptional start sites (Nishimura et al.,  1989).  In 
cartilage, the upstream promoter/transcriptional start site is 
predominantly activated, resulting in processing of the long 
form containing the 5' exons encoding the NC4  globular 
amino-terminal domain. It has been demonstrated that the 
downstream promoter/transcriptional start site (short form 
od[IX] mRNA) is predominantly used in the nonchrondro- 
genic tissues, including chicken primary cornea (Svoboda et 
al., 1988; Nishimura et al., 1989), nonchondrogenic regions 
of developing  chicken  forelimb  (Swiderski  and  Solursh, 
1992a), and notochord (Swiderski and Solursh, 1992b). The 
OP-l-dependent appearance of long-form type IX collagen 
strongly supports our inference that OP-1 induces chondro- 
genesis. 
Type X collagen is well known to be a specific molecule 
of hypertrophic cartilage (Linsenmayer et al.,  1988),  and it 
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tion (Linsenmayer et al.,  1991). While expression of both 
type U and IX collagen genes gradually diminishes through 
the culture period,  type X  collagen mRNA appears  only 
transiently after 6 d of OP-1 treatment (Fig. 3). Thus it ap- 
pears that OP-1 is capable not only of inducing chondrogene- 
sis, but also of promoting the further differentiation of chon- 
drocytes to a  hypertrophic state analogous to that which 
occurs in the growth plates of long bones. 
OP-1--dependent Chondrogenic Potential of 
Calvarial Cells 
Development of the calvaria follows the classical process of 
intramembranous ossification. Osteoblasts are derived from 
mesenchymal fibroblast-like precursors, or osteoprogenitor 
cells. Osteogenesis proceeds without histological evidence 
of cartilage involvement. However, there are elements of the 
embryonic chondrocranium associated with the distal re- 
gions of  the lambdoidal suture and small portions of  the adja- 
cent parietal and occipital bones. Rifas et al. (1982) showed 
that floating cells derived from ascorbate-free cultures of the 
calvarial chondrocranium could redifferentiate into chon- 
drocytes and form cartilage nodules in the presence of ascor- 
bate. To rule out the possibility that early OP-1 treatment was 
acting only on cells derived from the chondrocranium, cal- 
varial segments were dissected and studied separately (Table 
I). It is clear that alcian blue-stained clusters of hypertrophic 
chondrocytes can form from cells derived from all calvarial 
regions, although they are somewhat more abundant in the 
occipital and parietal bones. Another conclusion from se- 
quential calvarial digestion studies is that the greatest abun- 
dance of cells with OP-l-dependent chondrogenic potential 
occurs in digests III-V, ceils indigenous to the mineralizing 
osseous matrix which are also known to have the greatest os- 
teogenic potential. In contrast, cells from calvarial digest 
populations I and II, which are depleted of osteoprogenitor 
cells, show a poor chondrogenic response to OP-1. This sup- 
ports the hypothesis that pluripotent osteoprogenitor cells 
are the target ceils for OP-l-dependent chondroinduction. 
In the early stages of the cultures, OP-1 stimulates DNA 
synthesis. Because chondrogenic differentiation is also stim- 
ulated in this early period, there is an apparent contradiction 
to the general rule of an inverse relationship between cell 
proliferation and differentiation. However,  the  autoradio- 
gram of [3H]thymidine  incorporation into DNA at day 4 
shows that the clusters of large round cells which seem to be 
incipient chondrocytes induced by OP-1 do not incorporate 
[3H]thymidine,  while small cells surrounding the colonies 
do so intensively (Fig. 6 G). It is possible that OP-1 stimu- 
lates DNA synthesis in undifferentiated  progenitor cells, but 
is a weaker mitogen for differentiated cells. Judging from the 
typical hypertrophic chondrocyte cluster size of 2-20 cells, 
OP-1 allows ,ol-4 rounds of cell division in cells responding 
to the chondroinductive influence. 
Ascorbic acid is essential for the induction of chondrogen- 
esis by OP-1. In rat primary osteoblast-like cell cultures, as- 
corbate is known to be required for expression of the osteo- 
blastic  phenotype (Aronow  et al.,  1990),  and ascorbate 
induces alkaline phosphatase and mineralization in chick 
chondrocyte cultures (Leboy et al., 1989).  Though the pre- 
cise role of this vitamin in chondrogenesis and osteogenesis 
is still unclear, ascorbic acid is required for the hydroxyla- 
tion of proline and lysine residues and promotes collagen 
secretion (Kivirikko and MyUyla, 1987).  In a recent study 
of MC3T3-E1 osteoblasts, Franceschi and Iyer (1992) showed 
that expression of mature osteoblastic markers is reversibly 
blocked when collagen synthesis and secretion is inhibited 
by ascorbate deprivation or addition of proline analogs. It is 
likely that the existence of a properly assembled, mature col- 
lagenous extracellular matrix plays a critical role in the in- 
duction of chondrogenesis and osteogenesis. 
OP-1 Regulates the Commitment of 
Osteoprogenitor Cells 
Primary cultures prepared through sequential collagenase 
digestions of fetal or newborn rat calvaria have long been 
known to  possess  osteoblastic characteristics  (Wong  and 
Cohn, 1975; Bellows et al., 1986).  A temporal appearance 
of osteoblastic phenotypic markers in these in vitro systems 
is analogous to that seen in vivo in developing fetal rat cal- 
varia tissue (Aronow et al., 1990).  A similar correlation of 
temporal  expression  exists  for  embryonic chicken osteo- 
blasts (Gerstenfeld et al.,  1987).  Owen et al.  (1990)  pro- 
posed a model wherein primary rat calvarial cell cultures 
were considered to traverse three principal periods of os- 
teoblast development, consisting of proliferation, matrix de- 
velopment/maturation, and mineralization. They presented 
evidence that proliferation was downregulated before the on- 
set of events associated with osteoblast differentiation. 
The rat calvarial cell culture system which we have used 
expresses osteoblastic characteristics after confluence, and 
this osteogenesis is known to be amplified by OP-1 treatment 
after confluence. We reported previously that OP-1 stimu- 
lates osteoblastic properties  such as alkaline phosphatase 
activity, intracellular cAMP production in response to para- 
thyroid hormone (PTH), osteocalcin synthesis, and mineral- 
ization (Sampath et al.,  1992). 
Chondroinductive effects of OP-1, the focus of this study, 
are observed in rat calvarial cell primary cultures when ex- 
posure occurs early, during the proliferation phase before 
confluence.  It  is  noteworthy  that  early  OP-1 treatment 
decreases osteocalcin production when the level of osteocal- 
cin synthesis is relatively low (Fig. 5 and Tables II and IV). 
This suggests that OP-1 delays the osteoblastic differentiation 
of uncommitted osteoprogenitor cells, either by stimulating 
the proliferation of this subpopulation, or by diverting cells 
to a chondrogenic pathway. As the culture matures in the ab- 
sence of added OP-1, these progenitors either die or become 
increasingly committed to  the  osteoblastic lineage,  since 
later exposure to OP-1 promotes further maturation and ex- 
pression of  osteoblastic phenotypes by acting on the predom- 
inant target population of committed preosteoblasts and os- 
teoblasts in mature cultures (Sampath et al., 1992). Reversal 
of these committed cells by OP-1 from osteogenic to chon- 
drogenic fate apparently does not occur, and there is no obvi- 
ous  formation of chondrocytic clusters  during  late OP-1 
treatment. Table II also supports this inference by demon- 
strafing OP-1 enhancement of osteoblastic, but not chondro- 
cytic, markers in subcultivated cells. 
We have observed similar OP-1 effects on ROS 17/2.8 cells 
and  MC3T3-E1  cells  (unpublished  data):  OP-1 enhances 
both alkaline phosphatase activity and osteocalcin produc- 
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mature  osteoblasts  are  consistent  with  the  studies  using 
related TGF-B  superfamily proteins BMP-2,  BMP-4,  and 
BMP-3 (osteogenin) (Chen et al., 1991; Takuwa et al., 1991; 
Vukicevic et al., 1989). In the calvarial cell primary culture 
model, the chondrogenic versus osteogenic effects of OP-1 
are, therefore, primarily determined by the timing of the on- 
set of OP-1 treatment. 
The exact lineage of cells which differentiate into chondro- 
cytes under the influence of OP-1 is not yet known. The pri- 
mary rat calvarial cell population used in this study (digest 
III-V) is dominated by osteoprogenitor cells, preosteoblasts, 
and osteoblasts (Wong and Cohn, 1975; Bellows et al., 1986; 
Bellows and Aubin, 1989; Aronow et al., 1990). Clonal cell 
lines which have characteristics of immature versus mature 
stages  of  osteoblastic  differentiation  and  developmental 
commitment have been derived from rat calvaria (Yamaguchi 
and Kahn, 1991). Another clonally selected rat calvarial cell 
line was found to express the chondrocytic phenotype (Ber- 
nier et aI., 1990). Other evidence exists that a clonal cell line 
derived from fetal rat calvaria can differentiate into several 
cell types. RCJ3.1, clonally derived from the 21-d fetal rat 
calvaria, differentiates into four distinct phenotypes includ- 
ing  myoblasts,  mineralized  osteoblasts,  adipocytes,  and 
chondrocytes,  the  latter  after  dexamethasone  treatment 
(Grigoriadis et al.,  1988).  Kellerman et al. (1990) demon- 
strated that an SV-40 immortalized cell line derived from 
mouse teratocarcinoma differentiates into osteoblasts, chon- 
drocytes, and adipocytes under various culture conditions. It 
has also been shown that chick peri0steal cells (Nakahara et 
al., 1992), bone marrow cells (Berry et al., 1992),  and cal- 
varial cells (Manduca et al., 1992) contain osteoprogenitor 
cells that are capable of differentiating into osteoblasts or 
chondrocytes. 
The hypothesis that early OP-1 treatment targets uncom- 
mitted osteoprogenitor cells is supported by our findings, but 
we cannot rule out the possibility that OP-1 stimulates carti- 
lage phenotypic expression among cells already committed 
to the chondrocytic lineage. The frequency of hypertrophic 
chondrocyte colonies induced by OP-1 is '~0.7 % of plated 
cells in our experiments. Bellows  and Aubin (1989) deter- 
mined an osteoprogenitor cell frequency of 0.3% in the rat 
calvarial cell culture system by limited dilution counting of 
mineralized nodules. 
TGF-B1 appears to strongly influence osteoprogenitor cell 
commitment in this primary culture model. The phenotypic 
changes (Table  IV) and the fibroblastic appearance of the 
TGF-/~l-treated calvarial cells, even in the presence of 40 
ng/ml OP-1 (Fig. 7, B and D), suggests that TGF-B1 causes 
diversion of the uncommitted osteoprogenitor cells  from 
both chondrogenic and osteogenic fates. This contrasts with 
reported TGF-B1 effects in vivo where subperiosteal injec- 
tions of 200 ng/day in the rat femur cause elevated chondro- 
genesis (Joyce et al.,  1990). 
OP-1 Treatment In Vitro as a Model  for 
Endochondral Ossification 
In primary calvarial cultures, OP-1 induces chondrogenesis 
and fosters further differentiation  of  chondrocytes to a hyper- 
trophic state.  These centers of hypertrophic chondrocytes 
which develop in response to OP-1 in vitro appear to "nucle- 
ate" and organize local osteogenesis and mineralized nodule 
development (Fig. 6), just as calcified cartilage in the en- 
dochondral growth plate acts as a substratum for osteoblastic 
bone formation in vivo. 
Differentiated chondrocytes are known to produce growth 
factors such as basic FGF which may locally stimulate os- 
teoblast proliferation (Hauschka et al.,  1986).  A heparan- 
and chondroitin-SO4-rich proteoglycan, betaglycan, is the 
class HI TGF-/~ receptor (Cheifetz et al., 1987) and in a solu- 
ble, mobile form, betaglycan has been implicated in TGF-B 
binding to the extracellular matrix (Andres et al.,  1989). 
Might  proteoglycans  such  as  betaglycan,  decorin  (DS- 
PGII), and biglycan (DS-PGI) play a role in tethering OP-1 
to  the  matrix  surrounding  hypertrophic  chondrocytes, 
thereby allowing a localized osteogenic response? 
We have presented evidence in support of the hypothesis 
that OP-1 induces the differentiation of chondrocytes from 
uncommitted osteoprogenitor cells. It is possible that OP-I 
is naturally involved in the induction of chondrocytes from 
these progenitors, thus playing an essential role in normal 
developmental and tissue repair processes of  the skeletal sys- 
tem in vivo. 
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